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Available online 18 July 2016Despite the common assumption that genetic generalized epilepsies are characterized by a macroscopically nor-
mal brain on magnetic resonance imaging, subtle structural brain alterations have been detected by advanced
neuroimaging techniques in Childhood Absence Epilepsy syndrome. We applied quantitative structural MRI
analysis to a group of adolescents and adults with Juvenile Absence Epilepsy (JAE) in order to investigate
micro-structural brain changes using different brainmeasures.We examined greymatter volumes, cortical thick-
ness, surface areas, and subcortical volumes in 24 patients with JAE compared to 24 healthy controls; whole-
brain voxel-basedmorphometry (VBM) and Freesurfer analyseswere used.When compared to healthy controls,
patients revealed both greymatter volume and surface area reduction in bilateral frontal regions, anterior cingu-
late, and right mesial-temporal lobe. Correlation analysis with disease duration showed that longer disease was
correlatedwith reduced surface area in right pre- and post-central gyrus. A possible effect of valproate treatment
on brain structures was excluded. Our results indicate that subtle structural brain changes are detectable in JAE
and are mainly located in anterior nodes of regions known to be crucial for awareness, attention and memory.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Childhood Absence Epilepsy (CAE) and Juvenile Absence Epilepsy
(JAE) are two sub-syndromes of Genetic Generalized Epilepsy (GGE;
formerly known as idiopathic generalized epilepsies) whose hallmark
seizures are represented by absences (Fisher et al., 2005). CAE is a child-
hood epilepsy syndrome occurring in 10–17% of all childhood onset ep-
ilepsy, making it the most common paediatric epileptic syndrome. JAE
usually begins between 10 and 17 years of age, but, at lower age limit,
there is a great deal of overlap with CAE. By deﬁnition, GGE patients
have no abnormalities on visual inspection of brain magnetic resonance
imaging (MRI), but recently focal structural and functional abnormali-
ties are emerging from studies using advanced MRI techniques. Volu-
metric studies using voxel-based morphometry (VBM) have shown
both regional cortical grey matter (GM) and thalamic volumes alter-
ations in GGE compared to controls: thalamic volume reduction was
the most consistent ﬁnding across all the studies, while both increased
and decreased cortical volumes were found (Seneviratne et al., 2014).
Among all GGEs, only few studies have analysed structural MRI speciﬁ-
cally in absence epilepsy patients separately fromother sub-syndromes,
and studies mainly focused to investigate populations with childhood
onset absence seizures. Chan et al. (2006) compared CAE with controlsMetabolic, and Neural Science,
ital, via Giardini 1355, 41126
).
. This is an open access article underand found areas of GM decrease in both thalami and in the subcallosal
gyrus together with white matter reduction in extranuclear subcortical
areas and basal forebrain (Chan et al., 2006). Pardoe et al. (2008), found
a consistent reduction in thalami volume in CAE both within and across
three different sites ofMRI acquisition (Pardoe et al., 2008). Caplan et al.
(2009) demonstrated that children with CAE have smaller grey matter
volumes in orbito-frontal gyrus and in bilateral temporal lobe compared
to children without epilepsy (Caplan et al., 2009). Finally, in a study
analysing both CAE and JAE, an increased GM volume in superior
mesio-frontal regions was reported in patients compared to controls
(Betting et al., 2006). In conclusion, despite some variability in the loca-
tion and direction of volumetric changes, there is an emerging body of
evidence suggesting that subtle alterations in brain structure occur in
absence epilepsy syndromes. This heterogeneity could be due to several
factors, including mixed patients groups, different neuroimaging tech-
niques, different sample size, and publication bias reporting only posi-
tive results. In addition, if we consider recent evidence suggesting that
GGE syndromes are neurodevelopmental disorders with different pat-
terns of prospective grey and white matter volume changes across
childhood and adolescence (Hermann et al., 2006; Tosun et al., 2011a;
Tosun et al., 2011b), one would expect distinct structural imaging pat-
terns in CAE and JAE patients. Given the lack of speciﬁc structural neu-
roimaging studies on juvenile onset of Absence Epilepsy, we focused
our study on JAE. We analysed cortical and subcortical brain changes
in patients compared to healthy controls by means of different
methods/measures: VBM, cortical thickness and surface, and subcortical
volumes. We also correlated MRI abnormalities with the clinicalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mentwith sodiumvalproate on the brain structure (Pardoe et al., 2013).
2. Methods
2.1. Subjects
Twenty-four patients with JAE were recruited. Diagnosis of JAE was
based on electroclinical criteria according to the International League
Against Epilepsy (ILAE) classiﬁcation (Berg et al., 2010). Demographic
data and clinical information such as age of seizure onset, duration of
epilepsy, antiepileptic drugs (AED) prescription and response to treat-
ment, were collected. For group comparison, 24 volunteers were re-
cruited to serve as healthy controls (HC). Healthy subjects had no
history of neurological diseases or family history of epilepsy. All sub-
jects, both patients and controls, had normal MRI at visual inspection.
The human ethic committee of the University of Modena and Reggio
Emilia approved this study and written informed consent was obtained
from all the patients recruited and their parents if underage.
2.2. MRI acquisition
Three-dimensional (3D) T1-weighted MRI images were acquired
using a 3 Tesla Philips Intera MRI scanner (Best, The Netherlands). A
SPGR pulse sequence (echo time (TE) = 4.6, repetition time (TR) =
9.9 ms) was used. One hundred seventy contiguous sagittal slices
were acquired (voxel size = 1 × 1 × 1 mm) and the ﬁeld of view was
240 mm with a matrix size of 256 × 256 × 170. A T2-weighted axial
scanwas also acquired to allow visual determination of vascular burden
or tissue abnormalities.
2.3. Statistical analysis of demographical and clinical variables
Demographical and clinical characteristics of subjects were analysed
using Stata11 software and parametric and non-parametric statistics
were used as appropriate. Independent samples t-tests were used to
compare age and years of education between patients and controls;
chi-square was used to compare the two groups according to gender.
2.4. Voxel-based morphometry analysis
VBM was performed using VBM8 (http://dbm.neuro.uni-jena.de/
vbm/) a toolbox of SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm/); default
settings were applied. Structural images were bias-corrected, tissue-
classiﬁed, and normalized to standard template using high-dimensional
DARTEL normalization. Grey-matter volumewas calculatedmodulating
the normalized segmented images with a non-linear only warping
resulting in an analysis of relative differences in regional grey-matter
volumes corrected for individual brain size. To check the quality of the
segmentation and normalization procedures, the normalized, bias-
corrected images were visually inspected and covariance between nor-
malized imageswas calculated to check homogeneity of variance and to
identify potential outliers. Finally the normalized, segmented, andmod-
ulated images were smoothed with a 8 mm FWHM isotropic Gaussian
kernel. To identify GM differences between JAE and controls, we per-
formed a t-test comparison between the two groups and a double statis-
tical threshold was used (voxel-wise p b 0.001 and cluster size ≥686
voxels, as determined by AlphaSim with 10,000 Monte Carlo simula-
tions) to obtain an overall alpha level of b0.05 (see details on the proce-
dure at http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim) (Forman
et al., 1995). In addition, a correlation analysis with GM volume and dis-
ease duration was performed in the patients' group and a statistical
threshold of p b 0.001 with a cluster size ≥808 voxels was accepted. Fi-
nally, we performed a t-test comparison between patients taking
valproate (either alone or in polytherapy, VPA+) versus patients not
taking valproate or drugs-free (VPA−) at the time of MRI. In thismodel a double statistical threshold of p b 0.001 with a cluster size
≥785 voxels was used. In all analyses, age, gender, and education were
entered as covariates of no interest in order to control results for the po-
tential effect of these variables.
2.5. Cortical and subcortical Freesurfer analyses
Scans were analysed using standardized image toolbox (Freesurfer,
version 5.0) (Fischl, 2012), quality assurance (outlier detection based
on inter quartile of 1.5 standard deviations along with visual inspection
of segmentations), and statistical methods. Brieﬂy, the pipeline involves
removal of non-brain tissue, automated Talaraich transformation, seg-
mentation of white matter and grey matter, tessellation of grey/white
matter boundary, automated correction of topology defects, surface de-
formation to form the grey/white matter boundary and grey/cerebro-
spinal ﬂuid boundary, and parcellation of cerebral cortex. Cortical
thickness estimates were calculated as the distance between the grey/
white matter border and the pial surface at each vertex; surface area
was derived by taking the sum of the area of the vertices in each
parcellation. Labels were constructed and values were extracted based
on automatic algorithm (Desikan et al., 2006; Fischl et al., 2004). Ac-
cording to previous literature (Jalbrzikowski et al., 2013), we combined
caudal and rostral regions of themiddle frontal cortex and anterior cin-
gulate respectively tomake a unique label; the same approachwas used
to combine pars orbitalis, pars triangularis, and pars opercularis to cre-
ate the inferior frontal cortex label. In conclusion, we calculated cortical
thickness and surface area measures from 30 regions for hemisphere.
Subcortical volumes were calculated with FreeSurfer's automated pro-
cedure for volumetricmeasures. Each voxel in the normalized brain vol-
ume was assigned to one label using a probabilistic atlas obtained from
a manually labeled training set (Fischl et al., 2002). The labels we used
for the analysis were the putamen, caudate nucleus, globus pallidus, nu-
cleus accumbens, thalamus, amygdala, hippocampus, and the ventricu-
lar system.
After visual inspection and quality control, one patientwas removed
from analyses because of poor segmentation. Statistical analyses were
performed using SPSS software (IBM, Chicago, IL). All neuroanatomical
measures were examined for normality using Shapiro-Wilk test and
transformed appropriately if they violated assumptions of normality.
To compare cortical and subcortical measures between patients and
controls, we conducted a univariate ANCOVA with each neuroanatomi-
cal value as the dependent variable, group diagnosis as ﬁxed factor, and
age, gender, education, and intracranial volume as covariates. The same
approachwas uses to compare patients taking valproate (VPA+) versus
patients not taking valproate (VPA−) at the timeofMRI. False discovery
rate (FDR)was used to correct formultiple comparisons and a threshold
of q b 0.05 estimated using SPSS command, according to Bejamini and
Hochberg methods (Bejamini and Hochberg, 1995), was considered
statically signiﬁcant. Finally, we performed a correlation analysis in
the patient group between both cortical and subcortical neuroanatomi-
cal measures and disease duration calculated in years; for this analysis,
we regressed out the effect of education, age, total brain volume, and
gender and we considered signiﬁcant results with a p b 0.05, corrected
for multiple comparisons.
3. Results
3.1. Demographical and clinical characteristics
JAE patients (n = 24) had a mean age of 26.33 years (±11.9; range
16–52); 19 were female. Mean age of onset was 13.8 years (range be-
tween 10 and 24 years of age); mean duration of epilepsy was
12.9 years. Control subjects (n = 24) had a mean age of 30.6 years
(±5.4; range 19–38); 14 were female. Patients and controls only dif-
fered in years of education (p = 0.000), with controls showing higher
level of education (17.2 years ± 1.38) compared to patients
Table 1
Demographical and clinical characteristic of patients. Gender: F, female;M,male. Seizure types: A, absence; TC, tonico-clonic;M,myoclonic. Anti-epileptic drugs (AED): PB, phenobarbital;
VPA, sodium valproate; LEV, levetiracetam; TPM, topiramate; CBZ, carbamazepine; LTG, lamotrigine; CLB, clobazam.
Pt. ID Age at MRI (years) Gender Seizures onset (years) Disease duration (years) Past seizures types AED Seizure-free N1-year
1 26 F 12 14 A PB Yes
2 21 M 15 6 A; TC VPA Yes
3 22 F 15 7 A; TC; M LEV Yes
4 16 F 10 6 A VPA Yes
5 16 M 12 4 A; TC Drug-naive Yes
6 52 F 16 36 A; TC VPA No
7 19 F 12 7 A; TC VPA Yes
8 23 F 16 7 A; TC VPA Yes
9 20 F 12 8 A; TC VPA Yes
10 20 F 13 7 A VPA Undetermined
11 18 M 16 2 A; TC VPA Yes
12 45 F 10 35 A LEV Yes
13 19 F 12 7 A; TC VPA Yes
14 28 M 18 10 A; TC PB;TPM No
15 31 F 14 17 A Drug-free Undetermined
16 48 F 13 35 A LEV No
17 37 F 13 24 A; TC CBZ; PB No
18 19 F 10 9 A VPA; LTG; CLB No
19 16 F 14 2 A VPA Yes
20 21 F 11 10 A; TC VPA No
21 17 M 17 0 A; TC Drug-naive Yes
22 41 F 12 29 A; TC VPA;TPM Yes
23 45 F 16 29 A; TC Drug-free Yes
24 24 F 24 0 A; TC LEV; CLB No
Table 2
VBM group comparison results: areas of decreased volume in patients compared to con-
trols. Only regions surviving to the statistical threshold (voxel-wise p b 0.001 and cluster
size ≥686 voxels, as determined by AlphaSim with 10,000 Monte Carlo simulations) are
showed. L, left; R, right; MNI, Montreal Neurological Institute.
Region Cluster size t
MNI coordinates
x y z
R, Hippocampus 1173 4,42 40 −12 −19
R, Parahippocampus 20 −9 25
R, Amygdala 25 3 −27
R, Superior temporal gyrus 1215 4,77 45 12 −16
R, Frontal medial orbital cortex 1030 4,73 7 54 −11
L, Frontal medial orbital cortex −5 56 −11
R, Calcarine cortex 1176 4,33 25 −56 6
R, Lingual gyrus (BA19–30) 8 −58 6
L, Anterior cingulate (BA32) 743 3,96 −3 36 8
R, Frontal superior gyrus (BA6–9) 928 4,67 9 26 41
L, Frontal superior gyrus (BA6–9) −3 25 44
L, Post-central gyrus (BA3) 731 4,43 −43 −19 52
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age (p = 0.11) and gender (p = 0.21).
Table 1 reports demographical and clinical characteristics of each
patient.
Fifteen patients (62%) were seizure-free during the 12 months be-
fore MRI. 7 patients (29%) reported persistence of absence seizures.
For two patients seizures outcomes could not be established. As far as
AED prescription, 13 patients were taking sodium valproate at the
time of the study (11 in monotherapy; two in combination therapy)
with a mean daily dose of 870 ± 376 mg (mean plasma level of
59,8 ± 18,6 μg/mL; ‘therapeutic’ range 40–100 μg/mL). Eleven patients
were not taking sodium valproate (VPA− group; four were in mono-
therapy; three in combination therapy; four patients did not take any
drug).
3.2. VBM results
Group comparison analysis between patients and controls showed
that patients had reduced GM volume in several cortical regions com-
pared to controls, including right mesial-temporal lobe, right superior
temporal gyrus, bilateralmedial orbitofrontal cortex, right calcarine cor-
tex and lingual gyrus, left anterior cingulate, bilateral superior frontal
gyrus, and left post-central gyrus (Table 2, Fig. 1). No regions of in-
creased GM volume were detected in patients compared to controls.
Correlation analysis with disease duration after controlling for age, gen-
der, and education did not show signiﬁcant results. The direct compar-
ison between VPA+ and VPA− patients did not show signiﬁcant
differences for increased or decreased GM.
3.3. Freesurfer results
After correcting for multiple comparisons, patients had signiﬁcant
reduced surface area in rightmiddle frontal, right peri-calcarine, bilater-
al superior frontal cortices, aswell as in bilateral insula and anterior cin-
gulate. In contrast, after correcting for multiple comparisons, no
differences in cortical thickness emerged between the two groups, al-
though a trend towards signiﬁcance (p = 0.06) was found in anterior
cingulate and isthmus cingulate cortex (decreased cortical thickness in
patients compared to controls). Subcortical analyses conﬁrmed the vol-
ume reduction in right hippocampus and amygdala in patients versuscontrols. In Table 3 we reported signiﬁcant results for cortical and sub-
cortical group comparison analyses. The direct comparison between
VPA+ and VPA− patients did not show signiﬁcant differences for the
three measures. Finally, the correlation analysis with disease duration
showed a statistically signiﬁcant negative correlation in right pre-cen-
tral (r=−0.52) and post-central gyrus (r=−0.64) surfacemeasures,
meaning that longer disease was associated with decrease surface area
in these areas (Fig. 2). The potential effect of age on this correlation anal-
ysiswas controlled by adjusting for this variablewith partial correlation.
No correlation emerged for cortical thickness and subcortical regions
volumes.
4. Discussion
In this study, we investigated morphological and structural brain al-
terations in JAE patients and we found focal cortical and subcortical
areas reduction in several brain regions in patients compared to con-
trols. Conversely, no brain area showed increased values for any mea-
sure compared to controls. With regard to the population studied, the
clinical outcomes of our JAE population are in linewith previous studies
on the prognosis of juvenile onset absence epilepsy (Bartolomei et al.,
Fig. 1. VBM group comparison results. In blue are depicted areas of decreased volume in patients compared to controls; only regions surviving to the statistical threshold (voxel-wise
p b 0.001 and cluster size ≥686 voxels) are showed. The morphometric results are displayed onto the normalized SPM-glass brain (left images) and warped to the PALS-B12 atlas in
Caret (Caret, http://brainvis.wustl.edu/wiki/index.php/Caret:About; (Van Essen, 2005)) (mesial and dorsal view) for right (R) and left (L) hemisphere (right images).
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of seizure-free patients ranging from 60 to 85%. Our population is there-
fore representative of the syndrome of JAE, and does not feature a group
of patients with a more ‘severe’ disease respect with the usual clinical
practice.
Considering the observed cortical alterations, these involved exten-
sively brain regions known to participate in speciﬁc brain networks
(i.e. DefaultModeNetwork and Fronto-Parietal Network) devoted to at-
tention, goal-oriented cognition, and adaptive control processes (Cole et
al., 2014; Spreng et al., 2010;Uddin, 2015). In particular, we found alter-
ations located predominantly in the anterior nodes of these networks
(the orbito-frontal cortex, the anterior cingulate and insular cortex).
This ﬁnding suggests that a disruption of attention and awareness cir-
cuits is a core feature in absences epilepsies (Danielson et al., 2011;
Killory et al., 2011; Kim et al., 2014; Luo et al., 2011). In particular, the
orbito-frontal cortex was hypothesized to be important in absence sei-
zures generation (Holmes, 2004; Holmes et al., 2004) and abnormal
GM volume reduction in this area was previously found in CAE com-
pared to children without epilepsy (Caplan et al., 2009).
Interestingly, and quite unexpectedly, we found group differences in
surface area, but no differences emerged for cortical thickness (except
by lowering the statistical threshold). Several studies have shown dif-
ferent trajectories in cortical thickness and surface area changes across
childhood and adulthood (Aleman-Gomez et al., 2013; Raznahan et al.,
2011). Moreover, studies on psychiatric disorder like autism have
shown increased cortical thinning but comparable surface area growth
rates in adolescents with autism respect with controls (Wallace et al.,Table 3
Group comparisons signiﬁcant results for neuroanatomical cortical and subcortical mea-
sures extracted with Freesurfer.
Hemisphere F p Group comparison
Surface areas
Middle frontal R 13,78 0,001 CTR N PT
Superior frontal L 9,75 0,004 CTR N PT
R 13,64 0,001 CTR N PT
Insula L 15,62 0,000 CTR N PT
R 17,76 0,000 CTR N PT
Anterior cingulate L 12,38 0,001 CTR N PT
R 17,62 0,000 CTR N PT
Pericalcarine R 9,27 0,004 CTR N PT
Subcortical areas
Hippocampus R 8,04 0,007 CTR N PT
Amygdala R 5,13 0,003 CTR N PT2015). This evidence suggests that cortical surface and cortical thickness
measures might reﬂect independent neuropathological mechanisms.
Recent ﬁndings indicate that cortical thickness and surface area may
be driven by different genetic and neurobiological mechanisms involv-
ing different progenitor cells (Panizzon et al., 2009; Pontious et al.,
2008; Winkler et al., 2010). Therefore, if we consider that JAE is a
neurodevelopmental disorder and that cortical thickness and surface
may be the expression of different corticogenesis pathways, it is not sur-
prising to observe predominantly or selective alterations in one of the
two cortical measures (Jalbrzikowski et al., 2013).
With regards to the alterations observed at subcortical level our
study did not reveal a signiﬁcant thalamic atrophy in adults with JAE.
As a matter of fact, the thalamus volume reduction seen across the ma-
jority of studies on absence epilepsy was detected mainly in CAE sub-
jects (Chan et al., 2006; Pardoe et al., 2008), whereas the only other
study that included also JAE subjects did not ﬁnd thalamic changes in
whole-brain analysis (Betting et al., 2006). Several factors, beyond a
possible syndrome-speciﬁc effect, could contribute to this difference.
Possible explanations relate to the different age at fMRI, but also to dif-
ferent imaging analyses techniques. Moreover, not all previous studies
considered potentially confounding covariates (i.e age, gender) in the
analyses, therefore we cannot rule out a possible effect of these vari-
ables on reported results.
Interestingly, we observed a consistent mesial-temporal lobe vol-
ume reduction both with VBM and Freesurfer analyses. This ﬁnding is
in accordance with recent studies showing hippocampal damage and
spatial memory deﬁcits in animal models of absence epilepsy (Arcaro
et al., 2016; Jafarian et al., 2015;Marques-Carneiro et al., 2016). Howev-
er, human data on memory impairment in absence epilepsy are still
conﬂicting (Verrotti et al., 2015) and speciﬁc studies focusing on cogni-
tive-brain structure correlation should be performed to better analyse
this issue.
Considering the impact of disease duration on brain structures we
observed a negative correlation between ‘years of epilepsy’ and both
pre- and post-central gyrus surface area, even after adjusting the analy-
sis for age with partial correlation. This means that it is not ‘age’ per se
that leads to sensorymotor area reduction rather the interaction of epi-
lepsy with disease duration. The impact of disease duration on
sensorymotor cortex has also been reported in children with CAE
(Tosun et al., 2011b), in adults with GGE with tonic-clonic seizures
only (Bernhardt et al., 2009), as well as in adult temporal lobe epilepsy
patients with and without mesial temporal sclerosis (Bernhardt et al.,
2008; Mueller et al., 2009). This ﬁnding may not be speciﬁc to absence
epilepsy. However, it is important to highlight that this correlation in
Fig. 2. Correlation scatter plot between disease duration and surfacemeasures. In each graph, y axis represents surface areameasures as resulted from Freesurfer analysis, x axis represents
disease duration in years.
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result is the expression/consequence of repeated tonic-clonic seizures.
Indeed, in our JAE population the burden of generalized convulsion
was small. In particular, 15 out of 24 patients did not experience any sei-
zure in the 12-month before MRI and considering the remaining 9 pa-
tients only three of them reported 1 to 3 tonic-clonic convulsions in
the previous year. Notably, the involvement of the pericentral cortex
(and in particular of the somatosensory cortex) was observed both by
VBM and Freesurfer group comparisons and by the correlation analysis.
This ﬁnding corroborates evidence from animal and human studies for a
role of this brain region in absence generation and maintenance
(Blumenfeld, 2005; Polack et al., 2009; Tosun et al., 2011b).
Finally, an important secondary ﬁnding of our study concerns the
potential effects of sodium valproate on brain structure. This widely
used AED has been demonstrated to be associated with rare cases of re-
versible brain atrophy (Guerrini et al., 1998) and more recently to pari-
etal cortical thinning and whole brain volume reduction in different
epilepsy syndromes (Pardoe et al., 2013). Indeed, in our population,
morphometry changes were not driven by potential effects of valproate
treatment given the lack of difference in comparison between VPA+
and VPA− patients. However, considering our study and the one of
Pardoe et al. (2013), several possible factors can explain the different
ﬁndings. Importantly, beyond different analysis methodology, our pa-
tients' group differs for two important variables: ﬁrst, the mean
valproate dose exposure in our patients was about the half respect
with the one reported in the study of Pardoe et al. (2013); second, our
cohort shows a striking preponderance of female patients, while the
study of Pardoe was performed on male patients only. Given these dif-
ferences in patients' populations, it is conceivable if it is the dose of
valproate exposure and/or the subject gender that canmake a difference
on the effects of valproate on brain structures. It will be important to de-
sign future studies to address properly the effects on valproate treat-
ment (as well as of other drugs) on brain structure, possibly with
longitudinal pre/post treatment design.
4.1. Conclusion
Our study shows the presence of focal structural brain changes in JAE
syndrome detectable with advanced automated techniques; these
changes are mainly located in the medial frontal cortex, anterior cingu-
late, and mesial-temporal lobe, partially overlapping the anterior nodes
of attentional and awareness networks. The fact that quite overlapping
brain pattern alterations were detected with different neuroimagingapproaches gave a reasonable conﬁdence that subtle alterations in
these areas may be related to JAE syndrome. Larger and possibly longi-
tudinal studies will be required to conﬁrm these ﬁndings and to better
specify the link between structural abnormalities and clinical, neuro-
psychological, and electrophysiological data in absence epilepsy
syndromes.Study funding
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